351 related articles for article (PubMed ID: 23186332)
1. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
[TBL] [Abstract][Full Text] [Related]
2. Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acids.
Curtin V; Amharar Y; Gallagher KH; Corcoran S; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2013 Nov; 456(2):508-16. PubMed ID: 23994365
[TBL] [Abstract][Full Text] [Related]
3. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
4. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives.
Balani PN; Ng WK; Tan RB; Chan SY
J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526
[TBL] [Abstract][Full Text] [Related]
5. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
[TBL] [Abstract][Full Text] [Related]
6. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
7. Production of cocrystals in an excipient matrix by spray drying.
Walsh D; Serrano DR; Worku ZA; Norris BA; Healy AM
Int J Pharm; 2018 Jan; 536(1):467-477. PubMed ID: 29241701
[TBL] [Abstract][Full Text] [Related]
8. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
[TBL] [Abstract][Full Text] [Related]
9. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
10. Influence of polymer content on stabilizing milled amorphous salbutamol sulphate.
Balani PN; Wong SY; Ng WK; Widjaja E; Tan RB; Chan SY
Int J Pharm; 2010 May; 391(1-2):125-36. PubMed ID: 20211717
[TBL] [Abstract][Full Text] [Related]
11. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
[TBL] [Abstract][Full Text] [Related]
12. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
Veith H; Wiechert F; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
[TBL] [Abstract][Full Text] [Related]
13. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
Newman A; Zografi G
Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
[TBL] [Abstract][Full Text] [Related]
14. Studying the Impact of Modified Saccharides on the Molecular Dynamics and Crystallization Tendencies of Model API Nifedipine.
Kaminska E; Tarnacka M; Wlodarczyk P; Jurkiewicz K; Kolodziejczyk K; Dulski M; Haznar-Garbacz D; Hawelek L; Kaminski K; Wlodarczyk A; Paluch M
Mol Pharm; 2015 Aug; 12(8):3007-19. PubMed ID: 26101945
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Drug-Excipient Interactions in Biclotymol Amorphous Solid Dispersions.
Schammé B; Couvrat N; Tognetti V; Delbreilh L; Dupray V; Dargent É; Coquerel G
Mol Pharm; 2018 Mar; 15(3):1112-1125. PubMed ID: 29328661
[TBL] [Abstract][Full Text] [Related]
16. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A
Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
[TBL] [Abstract][Full Text] [Related]
17. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
[TBL] [Abstract][Full Text] [Related]
18. Slow dissolution behaviour of amorphous capecitabine.
Meulenaar J; Beijnen JH; Schellens JH; Nuijen B
Int J Pharm; 2013 Jan; 441(1-2):213-7. PubMed ID: 23219704
[TBL] [Abstract][Full Text] [Related]
19. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
Kalogeras IM
Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
[TBL] [Abstract][Full Text] [Related]
20. Selecting Excipients Forming Therapeutic Deep Eutectic Systems-A Mechanistic Approach.
Wolbert F; Brandenbusch C; Sadowski G
Mol Pharm; 2019 Jul; 16(7):3091-3099. PubMed ID: 31095911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
